Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation‐induced oral mucositis

Mucositis is a common and distressing side effect of chemotherapy or radiotherapy that has potentially severe consequences, and no treatment is available. The purpose of this study was to analyze the molecular pathways involved in the development of oral mucositis and to evaluate whether melatonin can prevent this pathology. The tongue of male Wistar rats was subjected to irradiation (X‐ray YXLON Y.Tu 320‐D03 irradiator; the animals received a dose of 7.5 Gy/day for 5 days). Rats were treated with 45 mg/day melatonin or vehicle for 21 days postirradiation, either by local application into their mouths (melatonin gel) or by subcutaneous injection. A connection between reactive oxygen species, generating mitochondria and the NLRP3 (NLR‐related protein 3 nucleotide‐binding domain leucine‐rich repeat containing receptor‐related protein 3) inflammasome, has been reported in mucositis. Here, we show that mitochondrial oxidative stress, bioenergetic impairment and subsequent NLRP3 inflammasome activation are involved in the development of oral mucositis after irradiation and that melatonin synthesized in the rat tongue is depleted after irradiation. The application of melatonin gel restores physiological melatonin levels in the tongue and prevents mucosal disruption and ulcer formation. Melatonin gel protects the mitochondria from radiation damage and blunts the NF‐κB/NLRP3 inflammasome signaling activation in the tongue. Our results suggest new molecular pathways involved in radiotherapy‐induced mucositis that are inhibited by topical melatonin application, suggesting a potential preventive therapy for mucositis in patients with cancer.

[1]  R. Reiter,et al.  Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations , 2012, Journal of pineal research.

[2]  Michael P. McCarthy,et al.  Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure. , 2005, International journal of radiation oncology, biology, physics.

[3]  Zhezhen Jin,et al.  Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases , 2014, Pediatric transplantation.

[4]  N. Kasthuri,et al.  Preclinical Efficacy of Melatonin to Reduce Methotrexate-Induced Oxidative Stress and Small Intestinal Damage in Rats , 2013, Digestive Diseases and Sciences.

[5]  James B. Mitchell,et al.  mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. , 2012, Cell stem cell.

[6]  R. Reiter,et al.  Sleep duration, melatonin and breast cancer in the Singapore Chinese Health Study: On null results and their interpretation , 2013, International journal of cancer.

[7]  C. N. Campos,et al.  Oral mucositis in cancer treatment: Natural history, prevention and treatment. , 2014, Molecular and clinical oncology.

[8]  D. Acuña-Castroviejo,et al.  Melatonin but not vitamins C and E maintains glutathione homeostasis in t‐butyl hydroperoxide‐induced mitochondrial oxidative stress , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  F. Kayaselçuk,et al.  Protective Effects of Melatonin and Octreotide Against Radiation-Induced Intestinal Injury , 2011, Digestive Diseases and Sciences.

[10]  Ximing Xu,et al.  Melatonin Reduces Inflammatory Injury Through Inhibiting NF-κB Activation in Rats With Colitis , 2005, Mediators of inflammation.

[11]  R. Reiter Melatonin: clinical relevance. , 2003, Best practice & research. Clinical endocrinology & metabolism.

[12]  F. Cunha,et al.  Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation , 2012, Cancer Chemotherapy and Pharmacology.

[13]  Yiqiang Zhang,et al.  Melatonin: a well‐documented antioxidant with conditional pro‐oxidant actions , 2014, Journal of pineal research.

[14]  H. Pawluk,et al.  Antioxidative effects of melatonin administration in elderly primary essential hypertension patients , 2008, Journal of pineal research.

[15]  K. Manda,et al.  AFMK, a melatonin metabolite, attenuates X‐ray‐induced oxidative damage to DNA, proteins and lipids in mice , 2007, Journal of pineal research.

[16]  L. Cerezo,et al.  Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  José A. García,et al.  Mitochondrial DNA and inflammatory diseases , 2011, Human Genetics.

[18]  S. Sonis,et al.  Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy , 2007 .

[19]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.

[20]  R. Reiter,et al.  A review of the molecular aspects of melatonin’s anti‐inflammatory actions: recent insights and new perspectives , 2013, Journal of pineal research.

[21]  José A. García,et al.  Melatonin-mitochondria interplay in health and disease. , 2011, Current topics in medicinal chemistry.

[22]  R. Reiter,et al.  Extrapineal melatonin: sources, regulation, and potential functions , 2014, Cellular and Molecular Life Sciences.

[23]  M. Martins,et al.  Effect of topical chamomile on immunohistochemical levels of IL-1β and TNF-α in 5-fluorouracil-induced oral mucositis in hamsters , 2013, Cancer Chemotherapy and Pharmacology.

[24]  F. Herrera,et al.  Mechanisms Involved in the Pro-Apoptotic Effect of Melatonin in Cancer Cells , 2013, International journal of molecular sciences.

[25]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[26]  S. Dimauro,et al.  Treatment of CoQ10 Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects , 2010, PloS one.

[27]  L. Fuentes-Broto,et al.  Role of melatonin in the regulation of autophagy and mitophagy: A review , 2012, Molecular and Cellular Endocrinology.

[28]  S. Mahdavi,et al.  Can Melatonin Help Us in Radiation Oncology Treatments? , 2014, BioMed research international.

[29]  M. Danson,et al.  Citrate synthase. , 2020, Current topics in cellular regulation.

[30]  R. Reiter,et al.  Melatonin identified in meats and other food stuffs: potentially nutritional impact , 2014, Journal of pineal research.

[31]  R. Reiter,et al.  Local Melatoninergic System as the Protector of Skin Integrity , 2014, International journal of molecular sciences.

[32]  E. Gnaiger Polarographic Oxygen Sensors, the Oxygraph, and High‐Resolution Respirometry to Assess Mitochondrial Function , 2008 .

[33]  A. Barrientos In vivo and in organello assessment of OXPHOS activities. , 2002, Methods.

[34]  J. Tschopp Mitochondria: Sovereign of inflammation? , 2011, European journal of immunology.

[35]  S. Sonis,et al.  Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. , 2007, Oral oncology.

[36]  M. Wajner,et al.  Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid , 2002, Neurochemistry International.

[37]  R. Hilf,et al.  A fluorometric method for determination of oxidized and reduced glutathione in tissues. , 1976, Analytical biochemistry.

[38]  R. Reiter,et al.  Analysis of the daily changes of melatonin receptors in the rat liver , 2013, Journal of pineal research.

[39]  Tao-Sheng Li,et al.  Mitochondrial dysfunction, a probable cause of persistent oxidative stress after exposure to ionizing radiation , 2012, Free radical research.

[40]  S. Sonis The pathobiology of mucositis. , 2004, Nature reviews. Cancer.

[41]  Yu-Wen Chung-Davidson,et al.  High-performance liquid chromatography with fluorescence detection and ultra-performance liquid chromatography with electrospray tandem mass spectrometry method for the determination of indoleamine neurotransmitters and their metabolites in sea lamprey plasma. , 2012, Analytica chimica acta.

[42]  A. Satterfield,et al.  TREATMENT , 1924, California and western medicine.

[43]  C. Lengerke,et al.  Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development , 2013, Journal of cellular and molecular medicine.

[44]  R. Jaskot,et al.  An automated analysis of glutathione peroxidase, S-transferase, and reductase activity in animal tissue. , 1983, Journal of analytical toxicology.

[45]  R. Reiter,et al.  N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  C. Schäfer,et al.  Clinical relevance. , 2010, Deutsches Arzteblatt international.

[47]  P. Itin,et al.  Anti-inflammatory treatment. , 2011, Current problems in dermatology.

[48]  D. Acuña-Castroviejo,et al.  Melatonin counteracts lipopolysaccharide‐induced expression and activity of mitochondrial nitric oxide synthase in rats , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  R. Reiter,et al.  Melatonin in the oral cavity: physiological and pathological implications. , 2015, Journal of periodontal research.

[50]  S. Sonis,et al.  Emerging evidence on the pathobiology of mucositis , 2013, Supportive Care in Cancer.

[51]  S. Mariathasan,et al.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation , 2007, Nature Reviews Immunology.

[52]  R. Reiter,et al.  On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK , 2013, Journal of pineal research.

[53]  D. Acuña-Castroviejo,et al.  Melatonin treatment normalizes plasma pro‐inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy , 2010, Journal of pineal research.

[54]  C. Duan,et al.  The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials , 2012, Cancer Chemotherapy and Pharmacology.

[55]  L. Galluzzi,et al.  Mitochondrial control of the NLRP3 inflammasome , 2011, Nature Immunology.

[56]  R. Reiter,et al.  Melatonin improves mitochondrial function in inguinal white adipose tissue of Zücker diabetic fatty rats , 2014, Journal of pineal research.

[57]  P. Srere,et al.  [1] Citrate synthase. [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)] , 1969 .

[58]  F. Herrera,et al.  Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells , 2013, British Journal of Cancer.

[59]  R. Reiter,et al.  The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. , 2013, Mini reviews in medicinal chemistry.

[60]  M. Imamura,et al.  The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice , 2010, Gastroenterology research and practice.